Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Veterans Health Administration, Greater Los Angeles Healthcare System, Los Angeles, California, USA.
BJS Open. 2021 Nov 9;5(6). doi: 10.1093/bjsopen/zrab098.
Robotic ventral hernia repair (VHR) has seen rapid adoption, but with limited data assessing clinical outcome or cost. This systematic review compared robotic VHR with laparoscopic and open approaches.
This systematic review was undertaken in accordance with PRISMA guidelines. PubMed, MEDLINE, Embase, and Cochrane databases were searched for articles with terms relating to 'robot-assisted', 'cost effectiveness', and 'ventral hernia' or 'incisional hernia' from 1 January 2010 to 10 November 2020. Intraoperative and postoperative outcomes, pain, recurrence, and cost data were extracted for narrative analysis.
Of 25 studies that met the inclusion criteria, three were RCTs and 22 observational studies. Robotic VHR was associated with a longer duration of operation than open and laparoscopic repairs, but with fewer transfusions, shorter hospital stay, and lower complication rates than open repair. Robotic VHR was more expensive than laparoscopic repair, but not significantly different from open surgery in terms of cost. There were no significant differences in rates of intraoperative complication, conversion to open surgery, surgical-site infection, readmission, mortality, pain, or recurrence between the three approaches.
Robotic VHR was associated with a longer duration of operation, fewer transfusions, a shorter hospital stay, and fewer complications compared with open surgery. Robotic VHR had higher costs and a longer operating time than laparoscopic repair. Randomized or matched data with standardized reporting, long-term outcomes, and cost-effectiveness analyses are still required to weigh the clinical benefits against the cost of robotic VHR.
机器人腹疝修复(VHR)已迅速普及,但评估临床结果或成本的相关数据有限。本系统评价比较了机器人 VHR 与腹腔镜和开放方法。
本系统评价按照 PRISMA 指南进行。从 2010 年 1 月 1 日至 2020 年 11 月 10 日,通过 PubMed、MEDLINE、Embase 和 Cochrane 数据库搜索与“机器人辅助”、“成本效益”和“腹疝”或“切口疝”相关的文章。提取术中及术后结果、疼痛、复发和成本数据进行叙述性分析。
符合纳入标准的 25 项研究中,有 3 项为 RCT,22 项为观察性研究。与开放和腹腔镜修复相比,机器人 VHR 的手术时间更长,但与开放修复相比,输血更少、住院时间更短、并发症发生率更低。机器人 VHR 比腹腔镜修复更昂贵,但在成本方面与开放手术无显著差异。三种方法的术中并发症、转为开放手术、手术部位感染、再入院、死亡率、疼痛或复发率均无显著差异。
与开放手术相比,机器人 VHR 手术时间更长、输血更少、住院时间更短、并发症更少。与腹腔镜修复相比,机器人 VHR 的成本更高,手术时间更长。仍需要随机或匹配数据以及标准化报告、长期结果和成本效益分析,以权衡机器人 VHR 的临床获益与成本。